chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient tested negative for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST NEGATIVE (Patient tested negative for COVID-19) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced SARS-COV-2 TEST NEGATIVE (Patient tested negative for COVID-19). At the time of the report, SARS-COV-2 TEST NEGATIVE (Patient tested negative for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, COVID-19: negative (Negative) nasal test negative. On 01-Feb-2021, COVID-19: negtive (Negative) saliva test negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported. Treatment for the event was not reported.  Patient was tested negative for COVID-19 yet quarantined still.
Patient complained of swelling and felling hot.  ECG done; Afib Benadryl 25 mg po given at 1530.  BP 132/80 O2 sat 96% RR 15 HR 84 - 110 irregular Pt released home.
Feeling miserable; Dehydrates quicker than normal; Joint pain; headache; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling miserable), DEHYDRATION (Dehydrates quicker than normal), ARTHRALGIA (Joint pain), HEADACHE (headache) and MYALGIA (Muscle pain) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Diabetic.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced FEELING ABNORMAL (Feeling miserable), DEHYDRATION (Dehydrates quicker than normal), ARTHRALGIA (Joint pain), HEADACHE (headache) and MYALGIA (Muscle pain). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (Feeling miserable), DEHYDRATION (Dehydrates quicker than normal), ARTHRALGIA (Joint pain), HEADACHE (headache) and MYALGIA (Muscle pain) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include Blood pressure medication and Diabetic medication. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-090387, US-MODERNATX, INC.-MOD-2021-090392 (E2B Linked Report). This case was linked to MOD-2021-090264 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090392:Husband dose 2 case US-MODERNATX, INC.-MOD-2021-090387:
Notes: 12/21/21 while at work developed Sx:  Fever, congestion, sore throat, runny nose, and tired. Tachycardic HR 130 at work, left mid shift and went to medical facility. patient denies recent travel or any direct exposures to COVID.  Instructed patient to quarantine 10 days from symptom onset, until 12/31/21 and then to call COVID hotline for RTW guidelines.  All questions answered.
Right deltoid -> localized injection site reaction. "Erythematous, macular, pink, warm to touch."
Starting 10 days after shot was administered, patient noticed 607 itchy red spots on various parts of his body, followed by very stiff neck, fever, aching joints, headache, tiredness, and general malaise. As of 9/24 (14 days after vaccine given) symptoms have improved, still a few spots but less red and aching joints still present but improved. Patient is under care of PCP and will also be consulting an immunologist to determine if he should receive the second dose or not. PCP is observing and did not suggest any specific treatment.
Parent reports pt to be crying and/or fussing non stop since immunizations. Describe a rash on her feet bilaterally. Afebrile. RN makes a home visit. Only rash that is visualized is one red raised bump (like a mosquito bite) on the left dorsal foot. Pt is being help and rocked by her dad and is going to sleep if not disturbed.
This spontaneous report was received from a medical assistance and refers to a multiple patients of an unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with a GARDASIL 9 injection (dose, route of administration, frequency, lot # and expiration date were not reported). Immediately, after receiving a GARDASIL 9, while the patients were still in the office, they developed episodes of syncope, which usually lasted for about 45 minutes. No treatment was given to the patients for the event. There was no product quality complaint involved. Subsequently, the patients were fully recovered and went home. The causality between event of syncope and GARDASIL 9 was not provided. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA002620.
I received the shot at 4:30 pm.  About an hour after receiving the shot, I felt a little dizzy, and my heart started beating faster.  My body felt weird.  I had a small headache and was very tired and laid down.  I fell asleep pretty quickly.   I woke up around 2:30 am the following morning, with a greater headache.  I took tylenol  for the headache.    I took another dose of tylenol 4 hours later.   I had loose stools, fatigue and my lungs felt heavy  (cough) for approx 12 hours.      Most symptoms resolved by the following day.   A little fatigue and heaviness remains.
covid vaccine breakthrough case   All doses Moderna dose 1 2/17/21  031M20A dose 2 3/17/21 040A21A dose 3 10/27/21 039D21A dose 4 7/12/22 038A22A
Pt recv vax on 3/5/99; on 3/6/99 pt exp swollen arm
Swelling, redness, heat and pain at injection site. Developed into cellulitis that reached elbow and required antibiotics.
I just tested positive for Covid; I just tested positive for Covid; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 17Dec2020 (first dose) as a single dose then via an unspecified route of administration on 07Jan2021 (second dose) as a single dose for COVID-19 immunization (lot number: EH9899 and expiration date: Apr2021 - for unspecified dose number). There were no medical history included and  concomitant medications. The patient had her second Pfizer Vaccine (Pfizer Covid-19 Vaccine) on 07Jan2021 and reported that she just tested positive for Covid yesterday (on 04Mar2021). The patient underwent lab tests and procedures which included COVID test: positive on 04Mar2021. The outcome of the events was unknown.  Information on lot/batch number has been requested.
Patient had received COVID 19 vaccination series of Pzifer 0.3ml on 2/26/2021, 3/19/2021. Additional dose of Moderna 0.5 ml given on 11/5/2021. Patient did not exhibit any clinical symptom, denies complaints after administration of additional dose of Moderna up to time of reporting incident.
On this date CDC required the Bivalent Booster and this patient was given the COVID-19 MOD 6-12/A Booster. He also was only given a .25 ml dose when this vial required a .5ml booster dose. He had no contact number to call back and give the rest of his dosage.
Very red, tender to the area and down to elbow. All glands were sore to touch, low grade fever and a small bump that looked like a chicken-pox pustule on leg, at knee.
pt recv vax 29JUL98 & seen by MD for increased bruising on 11AUG;adm to hosp;parents also report that pt exp fever, cough & cold sx about 1wk p/shot;adm diagnosis ITP;
Breakthrough case admission after 2 vaccines Pfizer 10/14/21 Lot# FF2590;  Pfizer 9/24/22 lot# GH969
Severe joint pain/hips/knees/elbos/neck/jaw/lower back.
Low antibody concentrations for multiple strains in the Prevnar 13; This is a spontaneous report from a contactable nurse via Pfizer sales representative.   A 16-year-old patient of an unspecified gender received four doses of pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) all on an unspecified date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. It was reported the patient had low antibody concentrations for multiple strains in the pneumococcal 13-val conj vac (dipht crm197 protein).   Information on the lot/batch number has been requested.
On 03/21/2021 at 6:15AM upon waking room was spinning, dizzy, severe headache. Same day but at 12:00PM same symptoms, 4:00PM same symptoms, 9:00PM same symptoms when going to bed. On 03/22/2021 I was very dizzy and had a headache upon waking and that continues to present day. I saw my doctor and was prescibed Meclazine that I take 3x per day. I also notified my Neurologist.
Adult female had COVID after Pfizer vaccine; Adult female had COVID after Pfizer vaccine; This is a spontaneous report from a contactable consumer. An adult female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single dose for COVID-19 immunization. Medical history and concomitant medications were not reported.On an unknown date, patient had COVID after Pfizer vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Red irritation about the size of a silver dollar at the injection site. It also itches. Started right after shot but has never gotten worse.
The HCP has a 38 year old who missed 2nd and 3rd doses of GARDASIL 9; Information has been received from a healthcare professional regarding a 38-years-old patient of unknown gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) as prophylaxis (dose, frequency, route of administration, anatomical location, lot number and expiration date were not provided).  On an unknown date, the patient missed her second and third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (missed dose).
Information regarding PREVNAR 13 was received from a healthcare professional regarding a 3-year-old female patient who experienced leg hurting and fever. At 3 years of age, the patient received a dose on 25-Jun-2010. The patient also received a dose of HIB (manufacturer unknown) on 25-Jun-2010. The patient experienced leg hurting and fever on 25-Jun-2010. The outcome is unknown. No additional information was available at the time of this report.
Patient required hospitalization due to breakthrough infection. He received Pfizer vaccine last dose in series on 02/25/21. Hospitalized from 07/27/21 to 07/29/21. Below is a copy from his discharge summary:   Pt. is a 85 y.o. male with a history of hypertension, hyperlipidemia and type 2 diabetes presented to the emergency department complaining of a low heart rate, dizziness and near syncope x2 days.  Heart rate 44 on admission, mildly hypertensive and afebrile.  Routine oxygen saturation on room air chest x-ray with ill-defined multifocal ground-glass opacities.  Patient tested positive for COVID-19 emergency department.  Troponin 04/20/2022, delta 0 21, delta 0. ECG with left bundle-branch block.  Potassium 5.5 creatinine 1.35,  glucose 260, AST 42, ALT 43.   Patient is discharged in stable condition with stable vital signs. All questions regarding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Right eye became slightly numb as well as right side of face apprx. 5 or 10 min after shot. Lasted about a day and a half. Also felt very bad. No fever. But congested second night. Each day felt better. As of Jan 22, 2021. Due to take second injection Jan 30, 2021. Is it ok? I feel alright.
Over 24hrs after vaccine administration mom noticed a red area on his right thigh. No pain, no itching.  Patient was seen in our office 48hrs after vaccine given and had an 8cm x 9cm area of redness, with mild swelling and warmth just distal to the injection site. Phone f/u with mom today (9/11/17) mom reports area is improved.
(+) Swelling, warm and redness @ injection site (L) deltoid (of arm). Advised to treat sx with ice pack to affected site BID-TID to reduce swelling and OTC TYLENOL for pain control.
3 days after first dose of vaccine I work up with moderate painful upper back neck muscle pain - as if I had injured  My muscle  neck area .... I did or had not firm any strenuous activity or moved or lifted anything heavy - I went to sleep and woke up with this pain I couldn?t turn my neck without feeling. Pain... I still as if today have a lot of  have upper back and neck  pain It has not improved much .
After her first booster dose the patient  had severe diarrhea.; After her first booster dose the patient was tired the next day; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (After her first booster dose the patient  had severe diarrhea.) and FATIGUE (After her first booster dose the patient was tired the next day) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939903, 007M20A and 005C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, the patient experienced DIARRHOEA (After her first booster dose the patient  had severe diarrhea.) and FATIGUE (After her first booster dose the patient was tired the next day). At the time of the report, DIARRHOEA (After her first booster dose the patient  had severe diarrhea.) and FATIGUE (After her first booster dose the patient was tired the next day) outcome was unknown.       No concomitant medication was reported. No treatment medications were reported.    This case was linked to MOD-2022-647022, MOD-2022-647021 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Sep-2022: Follow-up received included-vaccine lot numbers and vaccination dates updated.
Patient received a bivalent Pfizer vaccine when he should have received a monovalent Pfizer vaccine. He had not received any doses prior to receiving the bivalent vaccine
12 hours after injection, I experienced chills and body aches for several hours.  After taking tylenol, symptoms subsided.  I also had severe swelling, heat and soreness at the injection site for five days following injection.
Redness, swelling, pain + inflammation on left shoulder (around injection site) Got vaccination on 7/27/2020
Within 10-12 hours after vaccine administration, Pain/burning in left arm and severe body/muscle aches (8/10 on pain scale). Headache (4/10). Fatigue. Temperature 100.1. Took Ibuprofen and Tylenol 1st through 5th day. Temperature was under 99.0 by 4th day. Above side effects were bearable with Ibuprofen by 4th day and only arm soreness by 5th day. **Of note, I was diagnosed with COVID on September 11, 2020 and had since recovered.
Client vaccinated during drive-through event, in a remote, rural setting approx 40 minutes from nearest hospital, and instructed to wait 30 min due to past h/o anaphylaxis.  At 20 min post-vaccine, she reported feeling "funny," with swelling, tightness, and numbness in her face and inside of her mouth, although "not as bad as last time."   Noted to be tachy in the 130's, and making constant mouth movements due to the  increasing numbness.  After brief explanation, adult Epipen admin to rt thigh.  O2 sat remained in upper 90's throughout, and no resp distress was ever noted.  BP fluctuated between 96/60 and 142-92 during  the course of management.  50mg IM diphenhydramine followed the Epipen, as ambulance was enroute,  unknown ETA.  With constant monitoring, client reported chest tightness and variable feeing of swelling, tightness, and numbness inside her mouth and face/chin.  After 20 min, with some improvement of symptoms, transported by ambulance  to ED, where she received continued monitoring and steroid admin.  According to ER note, she was released to home after some hours of observation.
Itching started within 1-2 minutes of administration in her right upper arm and stayed in that area. She was given 25mg of oral liquid diphenhydramine and then observed. It improved within 10 minutes of receipt of the diphenhydramine.
A nurse reported that a 54 year old male received TD Absorbed for wound prophylaxis of a thigh laceration on 3/20/2000. On 3/21/2000, he developed atrial fibrillation, syncope, low grade fever and hypotension. He was hospitalized.
More tired than before and now have a low red blood cell count, as does my sister and niece, all who got the J&J vaccine. My sister got hers at the same place I did about an hour apart, and my niece got hers a couple weeks later. Now we're ALL anemic. I'm also a heart patient, so it's hit me pretty hard, where all I want to do is sleep. Someone called from VAERS and asked about my text report, and I said nothing was wrong. That's how out of it I've been. These vaccines were given WAY too early to know the long term, or even really, the short term effects beyond a few months. I now regret getting it, and would've been fine to just continue to mask up and social distance.
Red bumps on shoulder and neck spread to chest, back, legs, and arms. C/o itchiness exposed to Varicella disease.
Got the first dose of the Moderna vaccine on 19Feb2021 and did not get the second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Got the first dose of the Moderna vaccine on 19Feb2021 and did not get the second dose yet) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. B16H20T) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Got the first dose of the Moderna vaccine on 19Feb2021 and did not get the second dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Got the first dose of the Moderna vaccine on 19Feb2021 and did not get the second dose yet) had resolved.            Concomitant product use was not provided. Treatment information was not provided.
12:15pm Post vaccination reports feeling some dizziness, heart racing, w/ associated anxiety; medical monitoring w/vitals assessment: BP 162/109 P126 O2 sat 99%RA; rest, juice, and cookies offered. 1230pm Reports feeling better w/symptoms resolving, BP 144/80 P100. Released from facility w/self.
By evening was feeling achy; soreness in the shoulder/back area; soreness in the shoulder/back area; Soreness under arm gland area; This is a spontaneous report from a non-contactable consumer (patient) communicated to a Pfizer sales representative. A 6-decade-old male patient (in his 50s) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration on an unspecified date in 2021 (at the age of 6-decade-old) (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously taken first dose of COVID-19 (MANUFACTURER UNKNOWN) on unspecified date for covid-19 immunization. On an unspecified date in 2021, the patient reported that he received vaccine in the morning, by evening was feeling achy and continued to have soreness in the shoulder/back area, also soreness under arm gland area. Event took place after use of product. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot or batch number cannot be obtained.
pt recv vax 14FEB96 & 2 days p/vax mom states pt threw head back w/arms in air arched back, held breath & turned different colors (red, blue, purple);pt taken to ER-MD called pt floppy baby poss sz;poss epilepsy-asper;spasms of infancy;
Diagnosed with pertussis 9/26/17 was fully vaccinated-see attached record.
Approximately 12 hours post vax, the pt had a short febrile seizure. The pt fully recovered.
Lymphedema in left arm pit lymph node started after 1st vaccine dose.; This is a spontaneous report from a contactable consumer. A 40-years-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER2613), dose 1 via an unspecified route of administration, administered in Arm Left on 17Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included asthma, mitral valve prolapse and high blood pressure and pulses. Concomitant medications included cetirizine hydrochloride (ZYRTEC), flecainide (MANUFACTURER UNKNOWN) and valaciclovir hydrochloride (VALACYCLOVIR) and hydrochlorothiazide (MANUFACTURER UNKNOWN); all started on unknown dates and for unspecified indications. The patient was allergic to mild eggs, dairy, peanuts and severely to mushroom. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Apr2021, the patient experienced lymphedema in left arm pit lymph node which started after 1st vaccine dose. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event lymphedema in left arm pit lymph node was recovering, at the time of this report.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from an office manager refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with the doses of improperly stored GARDASIL 9 (lot # M030380 with expiration date 31-MAR-2019, lot # M030380 with expiration date 01-FEB-2019 and lot # M032650 with expiration date 31-MAR-2019; dose and route of administration were not reported) for prophylaxis. No adverse effects were reported. The vaccines were stored in 34.71 F for 24 hours and previously in 32.28 F for 8 hours and 46 minutes as well as 29.29 F for 96 hours. This is one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted. Sender's Comments: US-009507513-1612USA013573: US-009507513-1612USA013574.